Navigation Links
Alexza Receives Complete Response Letter for Adasuve™ NDA
Date:5/3/2012

n risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the potential of the Company to adequately address the issues in the recently received CRL, the timing of the Company's response to the CRL, the timing and prospects for regulatory approval to market ADASUVE in the U.S., the timing and prospects for regulatory approval to market ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries and the adequacy of the Company's capital to support the Company's operations, the Company's ability to raise additional funds and the potential terms of such potential financings. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... We are living a connected life in a ... and very soon we will be able to connect our ... life market has been valued by Frost & Sullivan at ... drive and manage this change to stay ahead of the ... Highlights of the congress include a groundbreaking keynote address showcasing ...
(Date:4/27/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... amniotic tissue and patent-protected processes to develop and ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... results for the first quarter of 2015. ... decision of its Board of Directors to authorize ...
(Date:4/27/2015)... BOSTON , April 27, 2015   Intarcia ... $225 million synthetic royalty financing with an equity conversion ... to use these funds to accelerate the initiation of ... vs. leading oral and injectable type 2 diabetes therapies. ... expected infrastructure and talent required to launch ITCA 650 ...
Breaking Medicine Technology:Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 2Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 3MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 2MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 3MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 4MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 5MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 6MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 7MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 8MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 9MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 10MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 11MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 12MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 13MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 14Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3
... at Society of NeuroInterventional Surgery ... ... results from,the US and Argentina reveal that a new minimally invasive ... condition that, in severe form, can cripple sufferers.,Announced today at the ...
... represents newest alternative surgical ... treatment, Dr. Carl Giordano - based in Morristown ... ... quicker recovery, MORRISTOWN, N.J., July 29 Leading New Jersey orthopedic,surgeon Dr. Carl ...
Cached Medicine Technology:New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition 2New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition 3NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs 2
(Date:4/28/2015)... Louis, Missouri (PRWEB) April 28, 2015 ... report that delves into the reality problem Americans have ... the population will need long-term care services as they ... need such care. , In the report, Carol ... organizations such as the American Health Care Association and ...
(Date:4/28/2015)... Once considered an unproven alternative to HID lighting, the ... storm with perfectly tailored light spectrums in an ideal, low ... than half of every SuperCloset and SuperRoom sold are now ... is gone and LED Grow Lights are here to stay. ... their first hand experience using the new LED Grow lights ...
(Date:4/28/2015)... Omaha, NE (PRWEB) April 28, 2015 ... federal district are among the top areas that healthcare ... Medical Group, aureusmedical.com, during the month of March 2015. ... which specializes in travel nurse jobs , ... hire positions within nursing and allied health fields. ...
(Date:4/28/2015)... April 28, 2015 PREVENT Life Safety, ... announced the relocation of their Southern California offices from ... 9380 7th Street, Unit I (letter I), Rancho Cucamonga, ... relocation was necessitated by the significant growth the company ... California. PREVENT will continue to provide superior life safety ...
(Date:4/27/2015)... Healthcare marketing specialists Smith & ... “Website Anatomy 101.” Available for download at ... elements for a successful hospital website. , ... experience, search results and lead generation strategy, healthcare ... website on patient volume and retention. This white ...
Breaking Medicine News(10 mins):Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2Health News:PREVENT Life Safety Moves to New Office in Rancho Cucamonga 2Health News:Smith & Jones Publishes 2015 Website Design White Paper 2
... pharmaceutical community, VIENNA, Va., Feb. 11 ... http://www.convera.com, a leading provider of vertical,search ... of,PharmaLiveSearch.com, a vertical search site specific to ... with Canon,Communications Pharmaceutical Media Group., ...
... of Directors as Chairman, NASHVILLE, Tenn., Feb. ... General Atlantic LLC (General,Atlantic) and affiliates of Hellman ... interests in Emdeon held by HLTH Corporation (Nasdaq:,HLTH). ... from HLTH in,November 2006., Emdeon also announced ...
... #1 FOR IMMEDIATE RELEASE , Recordable ... , Move over, compact discs, DVDs, and hard drives. ... protein-based memory device that could provide an alternative to ... approaching their memory storage capacities. Their study is scheduled ...
... Corporation,of America (Nasdaq: DCAI ) announced the ... Delaware County, Ohio which began construction,late last year, ... Everett commented, "Our newest facility in Ohio,opened earlier ... zero,deficiencies. The facility is in partnership with physicians ...
... to complementary or alternative medicine may not be accurate, ... -- Just 5 percent of Web pages devoted to ... complementary or alternative medicine are 15 times more likely ... a new study says. , Moreover, standard measures of ...
... to improve,prostate cancer imaging, WASHINGTON, Feb. 11 ... the Department of Health and Human,Services (HHS) and ... high priority" in the current for research and ... treatment of prostate,cancer. Such a federal investment in ...
Cached Medicine News:Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 2Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 2Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 9Health News:Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio 2Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 3Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 4
Corning 7078A multi-pack plugged capacity 5 mL...
Calibrated"to deliver"with blow-out, andpacked in a flip-top canister to keep the pipets racked. Feature: subdivision 0.1 mL volume 5.0 mL...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,160-2) ... assistance. Color: colour-coded ...
Medicine Products: